Search
for
Sort by
Research 61–90 of 1000+
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Issue Information - TOC
- Clinical Snippets
- Differentiating pulmonary lymphangioleiomyomatosis from pulmonary langerhans cell histiocytosis and Birt-Hogg-Dube syndrome
- Clinical Snippets
- Skin diseases in consequence of endocrine alterations
- Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study
- Parkinson's disease and skin
- Skin manifestations of chronic kidney disease
- The Spectrum of Skin Disease Among Indian Children
- Regulatory T cells in inflammatory skin disease: from mice to humans
- MicroRNA in skin diseases
- The Genetics of Human Skin Disease
- THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP
- Anaemia and skin disease
- Metabolism and skin diseases
- Skin Diseases in Pregnancy
- Microneedles meet photomedicine: emerging strategies for diagnosis and therapy of skin diseases
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Review paper The use of reflectance confocal microscopy in selected inflammatory skin diseases
- SKIN SURFACE CHEMISTRY AS A DIAGNOSTIC TOOL FOR SKIN DISEASES
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Exosomes as a novel pathway for regulating development and diseases of the skin (Review)
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases